Diastereoselective Synthesis of ψ[(E)-CMe=CH]- and ψ[(E)-CMe=CMe]-Type Dipeptide Isosteres Based on Organocopper-mediated anti-SN2′ Reaction

Organic Letters

Volumn 4, Issue 7, 2002, Pages 1055-1057

  Oishi, Shinya ^a   Niida, Ayumu ^a   Kamano, Takae ^a   Odagaki, Yoshihiko ^b   Tamamura, Hirokazu ^a   Otaka, Akira ^a   Hamanaka, Nobuyuki ^b   Fujii, Nobutaka ^a  

^a KYOTO UNIVERSITY   (Japan)

^b ONO PHARMACEUTICAL CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; DIPEPTIDE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ORGANOMETALLIC COMPOUND;

ALKYLATION; ARTICLE; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

ALKYLATION; COPPER; DIPEPTIDES; INDICATORS AND REAGENTS; ORGANOMETALLIC COMPOUNDS; STEREOISOMERISM;

EID: 0037018473     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol016835b     Document Type: Article

References (32)

1. Rose, G. D.; Gierasch, L. M.; Smith, J. A. Advances in Protein Chemistry; Academic Press: New York, 1985; pp 1-109.
2. (a) Chen, S.; Chrusciel, R. A.; Nakanishi, H.; Raktabutr, A.; Johnson, M. E.; Sato, A.; Weiner, D.; Hoxie, J.; Saragovi, H. U.; Greene, M. I.; Kahn, M. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 5872.
3. (b) Etzkorn, F. A.; Guo, T.; Lipton, M. A.; Goldberg, S. D.; Bartlett, P. A. J. Am. Chem. Soc. 1994, 116, 10412.
4. (c) Gillespie, P.; Cicariello, J.; Olson, G. L. Biopolymers 1997, 43, 191.
5. (d) Fink, B. E.; Kym, P. R.; Katzenellenbogen, J. A. J. Am. Chem. Soc. 1998, 120, 4334.
6. (e) Johannesson, P.; Lindeberg, G.; Tong, W.; Gogoll, A.; Karlén, A.; Hallberg, A. J. Med. Chem. 1999, 42, 601.
7. (f) Khalil, E. M.; Ojala, W. H.; Pradhan, A.; Nair, V. D.; Gleason, W. B.; Mishra, R. K.; Johnson, R. L. J. Med. Chem. 1999, 42, 628.
8. (g) Eguchi, M.; Lee, M. S.; Nakanishi, H.; Stasiak, M.; Lovell, S.; Kahn, M. J. Am. Chem. Soc. 1999, 121, 12204.
9. (h) Kim, H.-O.; Nakanishi, H.; Lee, M. S.; Kahn, M. Org. Lett. 2000, 2, 301.
10. (i) Estiarte, M. A.; Rubiralta, M.; Diez, A.; Thormann, M.; Giralt, E. J. Org. Chem. 2000, 65, 6992.
11. (j) Golebiowski, A.; Klopfenstein, S. R.; Shao, X.; Chen, J. J.; Colson, A.-O.; Grieb, A. L.; Russell, A. F. Org. Lett. 2000, 2, 2615.
12. (k) Smith, A. B., III; Wang, W.; Sprengeler, P. A.; Hirschmann, R. J. Am. Chem. Soc. 2000, 122, 11037.
13. (l) Alonso, E.; López-Ortiz, F.; Del Pozo, C.; Peralta, E.; Macías, A.; González, J. J. Org. Chem. 2001, 66, 6333.
14. For recent reviews of peptidomimetics, see: (a) Peptide Secondary Structure Mimetics. Tetrahedron (Symposia-in-print, no. 50; Kahn, M., Ed.) 1993, 49, 3444.
15. (b) Hanessian, S.; McNaughton-Smith, G.; Lombart, H.-G.; Lubell, W. D. Tetrahedron 1997, 53, 12789.
16. (c) Peptidomimetics Protocols; Kazmierski, W. M., Ed.; Humana Press; Totowa, NJ, 1999.
17. (d) Hruby, V. J.; Balse, P. M. Curr. Med. Chem. 2000, 7, 945.
18. (e) Kim, H.-O.; Kahn, M. Comb. Chem. High Throughput Screening 2000, 3, 167.
19. Gardner, R. R.; Liang, G.-B.; Gellman, S. H. J. Am. Chem. Soc. 1995, 117, 3280.
20. (a) Wipf, P.; Fritch, P. C. J. Org. Chem. 1994, 59, 4875.
21. (b) Wipf, P.; Henninger, T. C.; Geib, S. J. J. Org. Chem. 1998, 63, 6088.
22. (a) Ibuka, T.; Habashita, H.; Funakoshi, S.; Fujii, N.; Oguchi, Y.; Uyehara, T.; Yamamoto, Y. Angew. Chem., Int. Ed. Engl. 1990, 29, 801.
23. (b) Ibuka, T.; Habashita, H.; Otaka, A.; Fujii, N.; Oguchi, T.; Uyehara, T.; Yamamoto, Y. J. Org. Chem. 1991, 56, 4370.
24. (a) Ibuka, T.; Nakai, K.; Habashita, H.; Hotta, Y.; Fujii, N.; Mimura, N.; Miwa, Y.; Taga, T.; Yamamoto, Y. Angew. Chem., Int. Ed. Engl. 1994, 33, 652.
25. (b) Fujii, N.; Nakai, K.; Tamamura, H.; Otaka, A.; Mimura, N.; Miwa, Y.; Taga, T.; Yamamoto, Y.; Ibuka, T. J. Chem. Soc., Perkin Trans. 1 1995, 1359.
26. (c) Wipf, P.; Henninger, T. C. J. Org. Chem. 1997, 62, 1586.
27. (d) Tamamura, H.; Yamashita, M.; Nakajima, Y.; Sakano, K.; Otaka, A.; Ohno, H.; Ibuka, T.; Fujii, N. J. Chem. Soc., Perkin Trans. 1 1999, 2983.
28. (e) Oishi, S.; Tamamura, H.; Yamashita, M.; Odagaki, Y.; Hamanaka, N.; Otaka, A.; Fujii, N. J. Chem. Soc., Perkin Trans. 1 2001, 2445.
29. D-Phenylalanine derivatives 1 and 6 were utilized for the synthesis of D-Phe-ψ[(E)-CMe=CX]-D/L-Val-type EADIs as a model case in this communication. A dipeptide. D-Phe-L-Val, accommodates in the (i + 1)-(i + 2) position in the type II′ β-turn substructure of the cyclic RGD pentapeptide, cyclo(-Arg-Gly-Asp-D-Phe-Val-), previously reported: Haubner, R.; Finsinger, D.; Kessler, H. Angew. Chem., Int. Ed. Engl. 1997, 36, 1374.
30. The diastereomerically pure allyl alcohols 4a and 5a,b were readily purified by recrystallization from the diastereomixture, respectively. The syn-allyl alcohol 4b could not be isolated in this step, and thus the diastereomixture, which contained the syn-allyl alcohol 4b as a major isomer, was converted into the corresponding oxazolidin-2-one derivative 8b. The diastereomerically pure oxazolidin-2-one 8b was purified by recrystallization.
31. Ibuka, T.; Suzuki, K.; Habashita, H.; Otaka, A.; Tamamura, H.; Mimura, N.; Miwa, Y.; Taga, T.; Fujii, N. J. Chem. Soc., Chem. Commun. 1994, 2151.
32. Ibuka, T.; Habashita, H.; Funakoshi, S.; Fujii, N.; Baba, K.; Kozawa, M.; Oguchi, Y.; Uyehara, T.; Yamamoto, Y. Tetrahedron: Asymmetry 1990, 1, 389.